DB17698InvestigationalProtein Based Therapies
SerpinPC is a mutated alpha-1-antitrypsin (α1AT) and serine protease inhibitor being investigated for the treatment of hemophilia.
- Mechanism
- Curator reviewed
Pharmacologically active on Vitamin K-dependent protein C
Resolves to
Targets
What you can answer from here — as of July 08, 2026
Which drugs share a target with SerpinPC, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account